Nemes Rush Group LLC Maravai Lifesciences Holdings, Inc. Transaction History
Nemes Rush Group LLC
- $689 Billion
- Q3 2024
A detailed history of Nemes Rush Group LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Nemes Rush Group LLC holds 207 shares of MRVI stock, worth $1,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207
Previous 207
-0.0%
Holding current value
$1,022
Previous $1.48 Million
21.12%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MRVI
# of Institutions
227Shares Held
140MCall Options Held
237KPut Options Held
19.4K-
Gtcr LLC20.2MShares$99.5 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$69.2 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$58.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$48.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$41.3 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $650M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...